Medicare Enrolled

Dr. Bruce Richman, D.O.

Family Medicine · Quakertown, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
30 S WEST END BLVD, Quakertown, PA 18951
2152571736
In practice since 2007 (19 years)
NPI: 1609927441 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Richman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Richman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Richman

Dr. Bruce Richman is a family medicine specialist in Quakertown, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Richman performed 1,022 Medicare services across 412 unique beneficiaries.

Between the years covered by Open Payments, Dr. Richman received a total of $17,493 from 71 pharmaceutical and/or device companies across 1023 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Richman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in PA $17,493 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,022
Medicare services
Top 26% in PA for family medicine
412
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
656 $97 $160
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
243 $71 $110
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
61 $134 $160
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
43 $3 $20
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $45 $85
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,493
Total received (2018-2024)
Avg $2,499/year across 7 years
Top 2% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,023
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,365 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$128 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,924
2023
$2,475
2022
$3,469
2021
$2,706
2020
$2,112
2019
$2,087
2018
$1,720

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$428
AstraZeneca Pharmaceuticals LP
$383
Novo Nordisk Inc
$257
Supernus Pharmaceuticals, Inc.
$216
Amgen Inc.
$195
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$185
Xeris Pharmaceuticals, Inc.
$154
Otsuka America Pharmaceutical, Inc.
$132
Teva Pharmaceuticals USA, Inc.
$104
Almatica Pharma LLC
$104
Astellas Pharma US Inc
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Exact Sciences Corporation
$84
Janssen Pharmaceuticals, Inc
$75
Bausch Health US, LLC
$73
PFIZER INC.
$69
Esperion Therapeutics, Inc.
$52
GlaxoSmithKline, LLC.
$50
Bayer Healthcare Pharmaceuticals Inc.
$50
Lundbeck LLC
$45
Novartis Pharmaceuticals Corporation
$20
Lilly USA, LLC
$18
Tolmar, Inc.
$18
Verity Pharmaceuticals Inc.
$16
Braeburn Inc.
$15
Top 3 companies account for 36.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,039
Novo Nordisk Inc
$1,458
ABBVIE INC.
$1,371
Amgen Inc.
$1,188
Lilly USA, LLC
$860
Corcept Therapeutics
$670
Gilead Sciences, Inc.
$586
Janssen Pharmaceuticals, Inc
$551
PFIZER INC.
$522
Astellas Pharma US Inc
$517
SANOFI-AVENTIS U.S. LLC
$509
AbbVie Inc.
$490
Supernus Pharmaceuticals, Inc.
$424
Boehringer Ingelheim Pharmaceuticals, Inc.
$382
Amarin Pharma Inc.
$353
Bausch Health US, LLC
$345
Almatica Pharma LLC
$298
Teva Pharmaceuticals USA, Inc.
$285
Kowa Pharmaceuticals America, Inc.
$253
Allergan Inc.
$244
Novartis Pharmaceuticals Corporation
$242
Xeris Pharmaceuticals, Inc.
$239
Allergan, Inc.
$224
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$224
GlaxoSmithKline, LLC.
$207
Otsuka America Pharmaceutical, Inc.
$201
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$185
Esperion Therapeutics, Inc.
$180
Upsher-Smith Laboratories LLC
$143
Bayer Healthcare Pharmaceuticals Inc.
$136
Lundbeck LLC
$129
Bayer HealthCare Pharmaceuticals Inc.
$127
Eisai Inc.
$119
Amneal Pharmaceuticals LLC
$109
Merck Sharp & Dohme Corporation
$108
Dexcom, Inc.
$106
Merck Sharp & Dohme LLC
$103
Circassia Pharmaceuticals Inc
$103
Exact Sciences Corporation
$101
Alkermes, Inc.
$101
Tolmar, Inc.
$89
Evoke Pharma, Inc.
$74
AbbVie, Inc.
$54
Collegium Pharmaceutical, Inc.
$53
Indivior Inc.
$52
EVOKE PHARMA, INC.
$48
Biohaven Pharmaceutical Holding Company Ltd.
$47
Clarus Therapeutics Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$46
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$44
Biohaven Pharmaceuticals, Inc.
$42
Shire North American Group Inc
$38
IDORSIA PHARMACEUTICALS US INC
$35
Sunovion Pharmaceuticals Inc.
$35
Medtronic MiniMed, Inc.
$32
BioDelivery Sciences International, Inc.
$31
Daiichi Sankyo Inc.
$30
Orexo US, Inc.
$28
Axsome Therapeutics, Inc.
$28
Medicure Pharma Inc.
$25
Regeneron Healthcare Solutions, Inc.
$20
Adlon Therapeutics L.P.
$19
UPSHER-SMITH LABORATORIES LLC
$18
Abbott Laboratories
$17
Intra-Sana Laboratories
$17
Seqirus USA Inc
$16
Vertical Pharmaceuticals, LLC
$16
Verity Pharmaceuticals Inc.
$16
Kaleo, Inc.
$15
Braeburn Inc.
$15
Aytu Bioscience, Inc
$13
Top 3 companies account for 27.8% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AIRSUPRA · AJOVY · APLENZIN · ARISTADA · AUSTEDO · Aciphex · Aimovig · AirDuo Digihaler · Androgel · Austedo XR · BASAGLAR · BELBUCA · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BRIXADI · BUNAVAIL 2.1 mg 30-count box · BYDUREON · CAPLYTA · CHANTIX · Cologuard Collection Kit · DUAKLIR PRESSAIR · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · Evzio · FARXIGA · Fluad · FreeStyle Libre 2 · GIMOTI · GLYXAMBI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LOREEV XR · LYBALVI · LYRICA · Levemir · Livalo · MIGRANAL · MOUNJARO · MYRBETRIQ · Minimed 630G · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Prolia · QELBREE · QULIPTA · QUVIVIQ · Qelbree · RELEXXII · RELISTOR ORAL · RELTONE 200 MG · REXULTI · RYBELSUS · RYTARY · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SYMBICORT · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · TUDORZA PRESSAIR · Tlando · Tresiba · UBRELVY · VESICARE · VIAGRA · VIIBRYD · VIVITROL · VRAYLAR · VYVANSE · Vascepa · Veozah · Vivitrol · Vivitrol 380 mg · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xultophy 100/3.6 · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPBOUND · ZYPITAMAG · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in PA.

Looking for a family medicine specialist in Quakertown?
Compare family medicine physicians in the Quakertown area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,103
Per 100K population
170.7
County median income
$111,951
Nearest hospital
ST LUKE'S HOSPITAL - UPPER BUCKS CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Richman is a clinical cardiology specialist, with above-average Medicare volume (top 26% in PA), with low-engagement industry engagement in the top 2% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Richman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Richman performed 656 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Richman receive payments from pharmaceutical companies?
Yes. Dr. Richman received a total of $17,493 from 71 companies across 1,023 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Richman's costs compare to other family medicine physicians in Quakertown?
Dr. Richman's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Richman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →